Results 11 to 20 of about 2,429 (169)

Treatment of pretibial myxedema with intralesional immunomodulating therapy [PDF]

open access: yesTherapeutics and Clinical Risk Management, 2017
Ziwei Ren,1,* Min He,2,* Fang Deng,2 Yan Chen,1 Liyin Chai,1 Bing Chen,2 Wuquan Deng1 1Department of Endocrinology and Nephrology, Chongqing Emergency Medical Hospital (The Fourth People’s Hospital of Chongqing), 2Department of Endocrinology ...
Ren Z   +6 more
doaj   +3 more sources

Injected Hyaluronidase Reduces the Volume of Exogenous Hyaluronate Fillers in Mice and Results in Clinical Improvement in a Patient with Pretibial Myxedema [PDF]

open access: yesDermatopathology, 2016
Background: Hyaluronidases are essential for the breakdown of hyaluronate (HA) in tissues and may be used to prevent the adverse effects of HA fillers.
Sébastien Menzinger   +3 more
doaj   +3 more sources

Pretibial Myxedema

open access: yesIndian Journal of Dermatology, 1996
Pretibial myxedema is very rarely associated with Thyrotoxicosis. Here is a case report.
Gangopadhyay Ashok kumar
doaj   +2 more sources

Pre-tibial myxedema: treatment with intralesional corticosteroid [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2015
The pretibial myxedema is a manifestation of Graves' disease characterized by accumulation of glycosaminoglycans in the reticular dermis. The dermopathy is self-limiting but in some cases may cause cosmetic and functional damage.
Luana Oliveira Ramos   +4 more
doaj   +3 more sources

Severe Pretibial Myxedema

open access: yesThe International Journal of Lower Extremity Wounds, 2011
Although pretibial myxedema (PTM) occurs in 4.3% of patients with Graves’s disease, the most severe variant, elephantiasis nostras verrucosa, is found in less than 1% of cases.The most frequent location of infiltration is the lower extremities ...
Priya Gopie, Vijay Naraynsingh
core   +3 more sources

Thyroxine-Induced preradial myxedema

open access: yesIndian Dermatology Online Journal, 2019
Localized myxedema is most commonly described in patients with hyperthyroidism, especially Graves' disease. Although pretibial myxedema generally appears as indurated plaques on the shins, it has also been rarely reported in other areas such as the face,
Mary Zothanpuii Chhangte   +3 more
doaj   +2 more sources

Insidious-Onset Indurated Plaques on the Shins

open access: yesDermatopathology, 2021
A 64-year old male presented with a several-year history of an insidious-onset tender, itchy and xerotic rash on his lower legs. Past medical history was significant for Graves’ disease and Graves’ ophthalmopathy.
Rishi Agrawal   +2 more
doaj   +2 more sources

Pretibial Myxedema Associated with Euthyroid Hashimoto’s Thyroiditis: A Case Report [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2014
Pretibial myxedema (PM) is an infiltrative dermopathy which is seen in grave’s disease. It is also associated with hypothyroidism, but is infrequently seen in Hashimoto’s thyroiditis. Lesions are seen commonly over pretibial region as non-pitting oedema
Pragya A Nair   +2 more
doaj   +2 more sources

Alemtuzumab-Induced Graves' Disease Complicated by Pretibial Myxoedema: A Case Report. [PDF]

open access: yesCase Rep Endocrinol
Background Alemtuzumab, a monoclonal antibody targeting CD52, is associated with a high incidence of secondary autoimmune disease, most commonly thyroid dysfunction. Alemtuzumab‐induced Graves’ disease (AIGD) typically follows a relapsing course and may exhibit atypical or severe phenotypes during immune reconstitution (IR). Case Presentation We report
O'Brolchain A, Reda E.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy